Gelteq Limited Ordinary Shares (GELS) vs Soligenix, Inc. (SNGX)

A side-by-side comparison of Gelteq Limited Ordinary Shares and Soligenix, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Gelteq Limited Ordinary Shares logo
GELS
Gelteq Limited Ordinary Shares
$5M
$0.58HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Soligenix, Inc. logo
SNGX
Soligenix, Inc.
$5M
$0.36HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — GELS vs SNGX

growth of $100 · dividends reinvested · last 2y
GELS -81.5% (-57.0%/yr)SNGX -90.0% (-68.4%/yr)GELS compounded faster over this window
050100150Start $10020252026$18$10
GELS SNGX

GELS vs SNGX: by the numbers

  • •GELS is the larger company ($5M vs $5M market cap).
  • •Both run net losses; SNGX's is the smaller (0.00% vs -4011.86% net margin).

Metrics side by side

Valuation

MetricGELSSNGX
P/B ratio0.560.80

Profitability

MetricGELSSNGX
Gross margin100.00%0.00%
Operating margin-3317.65%0.00%
Net margin-4011.86%0.00%
ROE-42.05%-154.08%
ROIC-27.41%-161.69%

Growth (annualized)

MetricGELSSNGX
Total return CAGR (5Y)N/A-72.72%

Go deeper

Full GELS analysisFull SNGX analysisInteractive comparison tool

Dig into the metrics

Gelteq Limited Ordinary Shares ROESoligenix ROEGelteq Limited Ordinary Shares operating marginSoligenix operating marginGelteq Limited Ordinary Shares revenue growthSoligenix revenue growthGelteq Limited Ordinary Shares free cash flowSoligenix free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.